Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

111 POSTS 0 COMMENTS

War Hero from Ontario Featured in Psychedelic Documentary

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Updates...

You Don’t Have to Take Psychedelics to Benefit from Them —...

Somerville, Massachusetts, Passes Measure to Decriminalize Psychedelics

New Hawaii Senate Bill May See Psilocybin Mushroom Therapy Legalized

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One...

Former Vancouver Firefighter Declares Psychedelic Drug Saved His Life

Should Montreal Expect Psychedelic Revolution in the Near Future? Activists Think...

Experts Predict What 2021 Psychedelics Space Might Look Like

1 234...12 Page 3 of 12

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Psychedelic Drug Development Pipeline Updates (Q1’25)

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

CLINICAL RESEARCH ASSOCIATE